Literature DB >> 22065485

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Glenn N Levine, Eric R Bates, James C Blankenship, Steven R Bailey, John A Bittl, Bojan Cercek, Charles E Chambers, Stephen G Ellis, Robert A Guyton, Steven M Hollenberg, Umesh N Khot, Richard A Lange, Laura Mauri, Roxana Mehran, Issam D Moussa, Debabrata Mukherjee, Brahmajee K Nallamothu, Henry H Ting.   

Abstract

Entities:  

Keywords:  ACCF/AHA Practice Guidelines; acute coronarysyndromes; anticoagulants; antiplatelet agents; arrhythmias, cardiac; coronary angiography; coronary artery revascularization interventions: stents; drug delivery systems; drug therapy; heart diseases; myocardial revasularization; platelet aggregation inhibitor; ultrasound

Mesh：

Year:  2011        PMID： 22065485     DOI： 10.1002/ccd.23390

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


× No keyword cloud information.
  37 in total

1.  The trials and tribulations of percutaneous coronary intervention in hospitals without on-site CABG surgery.

Authors:  Scott Kinlay
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

Review 2.  The Tradeoff Between Shorter and Longer Courses of Dual Antiplatelet Therapy After Implantation of Newer Generation Drug-Eluting Stents.

Authors:  John A Bittl
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

3.  Development of a Catheterization and Percutaneous Coronary Intervention Registry with a Data Management Approach: A Systematic Review.

Authors:  Alireza Tabatabaei Tabrizi; Hamid Moghaddasi; Reza Rabiei; Babak Sharif-Kashani; And Eslam Nazemi
Journal:  Perspect Health Inf Manag       Date:  2019-01-01

4.  Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes.

Authors:  Markus Schmugge; Oliver Speer; Sabine Kroiss; Walter Knirsch; Oliver Kretschmar; Margaret L Rand; Manuela Albisetti
Journal:  Eur J Pediatr       Date:  2015-01-16       Impact factor: 3.183

5.  Overview of Technical and Cost Considerations in Complex Percutaneous Coronary Intervention.

Authors:  J Raider Estrada; Jonathan D Paul; Atman P Shah; Sandeep Nathan
Journal:  Interv Cardiol       Date:  2014-03

Review 6.  Physiological Assessment of Coronary Lesions in 2020.

Authors:  Mohsin Chowdhury; Eric A Osborn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-01-15

Review 7.  Antiplatelet Therapy in Percutaneous Coronary Intervention.

Authors:  Alexander C Fanaroff; Sunil V Rao
Journal:  Interv Cardiol Clin       Date:  2016-02-13

8.  Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.

Authors:  Charlotte H So; Mark H Eckman
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

9.  Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromes.

Authors:  Q Ren; C Ren; X Liu; C Dong; X Zhang
Journal:  Herz       Date:  2015-11-02       Impact factor: 1.443

10.  Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.

Authors:  Hui-Chao Pan; Xian-Hao Wu; Qian-Li Wan; Bao-Hong Liu And; Xu-Sheng Wu
Journal:  Exp Biol Med (Maywood)       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.